Radiotheranostics in oncology: Making precision medicine possible. (2023)
Attributed to:
Development of Metabolism Radiotracers to Probe Disease Pathology in Human Subjects with Cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3322/caac.21768
PubMed Identifier: 36622841
Publication URI: http://europepmc.org/abstract/MED/36622841
Type: Journal Article/Review
Volume: 73
Parent Publication: CA: a cancer journal for clinicians
Issue: 3
ISSN: 0007-9235